Glycosylated warfarin analogs and uses thereof
AssigneeWisconsin Alumni Research Foundation
InventorsJon S. Thorson, Shannon C. Timmons
Life of this patent
Estimating the term…
Abstract
The present invention discloses a set of glycosylated warfarin analogs which are useful as anti-tumor or anti-metastatic agents and as reagents for studying sugar uptake in cells.
Claims10
A composition comprising a warfarin neoglycoside having the general formula:
- wherein
- is a reducing sugar selected from the group consisting of L-xylose;
- D-lyxose;
- D-xylose;
- 2-deoxy-L-ribose;
- 2-deoxy-D-ribose;
- L-fucose;
- L-arabinose;
- D-ribose;
- L-lyxose;
- L-ribose;
- 2,3,4,6-tetra-O-acetyl-D-glucose;
- L-mycarose;
- 2,3,4,6-tetra-O-benzyl-D-glucose;
- 2,3,5-tri-O-benzyl-D-arabinofuranose;
- 2,3,4,6-tetra-O-benzyl-D-mannose;
- 2,3,5-tri-O-benzyl-D-ribofuranose;
- and 6-deoxy-D-glucose.
A composition comprising a warfarin neoglycoside produced when an aglycon warfarin analog containing a secondary alkoxylamine moiety having the structure:
- is contacted with a reducing sugar selected from the group consisting of L-xylose;
- D-lyxose;
- D-xylose;
- 2-deoxy-L-ribose;
- 2-deoxy-D-ribose;
- L-fucose;
- L-arabinose;
- D-ribose;
- L-lyxose;
- L-ribose;
- 2,3,4,6-tetra-O-acetyl-D-glucose;
- L-mycarose;
- 2,3,4,6-tetra-O-benzyl-D-glucose;
- 2,3,5-tri-O-benzyl-D-arabinofuranose;
- 2,3,4,6-tetra-O-benzyl-D-mannose;
- 2,3,5-tri-O-benzyl-D-ribofuranose;
- 6-deoxy-D-glucose;
- and mixtures thereof.
A method of treating cancer in a subject in need thereof comprising the step of contacting the cancer cells with an effective amount of one or more of a warfarin neoglyoside having the general formula
- wherein
- is a reducing sugar selected from the group consisting of L-xylose;
- D-lyxose;
- D-xylose;
- 2-deoxy-L-ribose;
- 2-deoxy-D-ribose;
- L-fucose;
- L-arabinose;
- D-ribose;
- L-lyxose;
- galactosamine;
- L-ribose;
- 2,3,4,6-tetra-O-acetyl-D-glucose;
- L-mycarose;
- 2,3,4,6-tetra-O-benzyl-D-glucose;
- 2,3,5-tri-O-benzyl-D-arabinofuranose;
- 2,3,4,6-tetra-O-benzyl-D-mannose;
- 2,3,5-tri-O-benzyl-D-ribofuranose;
- and 6-deoxy-D-glucose;
- or a pharmaceutically acceptable salt thereof.
A method of studying sugar uptake in cells comprising the steps of:
- (a) contacting cells with a warfarin neoglyoside having the general formula
- wherein
- is a reducing sugar selected from the group consisting of L-xylose;
- D-lyxose;
- D-xylose;
- 2-deoxy-L-ribose;
- 2-deoxy-D-ribose;
- L-fucose;
- L-arabinose;
- D-ribose;
- L-lyxose;
- 2,3,4,6-tetra-O-acetyl-D-glucose;
- L-mycarose;
- 2,3,4,6-tetra-O-benzyl-D-glucose;
- 2,3,5-tri-O-benzyl-D-arabinofuranose;
- 2,3,4,6-tetra-O-benzyl-D-mannose;
- 2,3,5-tri-O-benzyl-D-ribofuranose;
- and 6-deoxy-D-glucose, and
- (b) measuring the amount of the warfarin neoglycoside taken up by the cells.
Dependencies are inferred from the claim text.